Our study provides the first evidence on site-specific Medicare spending on chemotherapy adjusting for patient comorbid illnesses, cancer type, and other cancer-related risks.
|Original language||English (US)|
|Number of pages||1|
|Journal||The American journal of managed care|
|State||Published - Oct 1 2018|
All Science Journal Classification (ASJC) codes
- Health Policy